SARS-CoV-2 Proteins Induce IFNG in Th1 Lymphocytes Generated from CD4+ Cells from Healthy, Unexposed Polish Donors.
Anna SałkowskaIwona KarwaciakKaja KaraśJarosław DastychMarcin RatajewskiPublished in: Vaccines (2020)
The outbreak of the SARS-CoV-2 virus in December 2019 has caused the deaths of several hundred thousand people worldwide. Currently, the pathogenesis of COVID-19 is poorly understood. During the course of COVID-19 infection, many patients experience deterioration, which might be associated with systemic inflammation and cytokine storm syndrome; however, other patients have mild symptoms or are asymptomatic. There are some suggestions that impaired cellular immunity through a reduction in Th1 response and IFNG (interferon gamma) expression, as well as cross-reactivity with common cold coronaviruses, might be involved in the differential COVID-19 course. Here, we show that CD4+ cells isolated from unexposed healthy donors that were differentiated towards the Th1 lineage in the presence of SARS-CoV-2 proteins exhibited induction of IFNG. Interestingly, the same cells induced to differentiate towards a Th17 lineage did not exhibit changes in IFNG expression or Th17-related cytokines. This suggests the cellular response to SARS-CoV-2 viral proteins is primarily associated with Th1 lymphocytes and may be dependent on past infections with common cold coronaviruses or vaccinations that induce unspecific cellular responses, e.g., BCG (Bacillus Calmette-Guérin). Thus, our results might explain the high variability in the course of COVID-19 among populations of different countries.
Keyphrases
- sars cov
- respiratory syndrome coronavirus
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- induced apoptosis
- ejection fraction
- poor prognosis
- coronavirus disease
- peritoneal dialysis
- cell cycle arrest
- peripheral blood
- single cell
- patient reported outcomes
- signaling pathway
- dendritic cells
- endothelial cells
- case report
- immune response
- drug induced
- sleep quality